D022762Chemicals & DrugsD12.776.260.108.124D12.776.660.167D12.776.930.127.124590.997092CCAAT-Enhancer-Binding ProteinsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonFeiXingFei Xing PhD36.09032400000000-80.266491000000001713Xing, FeiAssistant ProfessorCancer BiologyWake Forest School of MedicineDavidHerringtonDavid M. Herrington MD, MHS36.08959100000000-80.26859900000000217Herrington, DavidProfessorAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessorJingzhongDingJingzhong Ding PhD36.08884000000000-80.27016200000000403Ding, JingzhongAssociate ProfessorBayardPowellBayard L. Powell MD36.08919100000000-80.2667780000000099Powell, BayardProfessor30309512Fu H, Xing F, Lv Y, Zeng B, You P, Liu JTissue & cellFu H, Xing F, Lv Y, Zeng B, You P, Liu J. ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth. Tissue Cell. 2018 Oct; 54:65-71.Tissue Cell2018-08-18T00:00:002018ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth.24Assistant ProfessorInternal Medicine, Cardiovascular MedicineInternal Medicine, Gerontology & Geriatric MedicineInternal Medicine, Hematology & OncologyUrologyhttp://www.wfirm.orgWFIRM34907338Hsu CC, Tsai YS, Lin HKCell researchHsu CC, Tsai YS, Lin HK. UHRF1: a novel metabolic guardian restricting AMPK activity. Cell Res. 2022 01; 32(1):3-4.Cell Res2022-01-01T00:00:002022UHRF1: a novel metabolic guardian restricting AMPK activity.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor15735691Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SPOncogeneBerquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 2005 Apr 28; 24(19):3177-86.Oncogene2005-04-28T00:00:002005Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.12600983Wang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A, Wollheim CBThe Journal of biological chemistryWang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A, Wollheim CB. The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J Biol Chem. 2003 May 09; 278(19):16622-9.J Biol Chem2003-02-24T00:00:002003The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction.18809607Marcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus CD, Liu CG, Ruppert AS, Powell BL, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CDJournal of clinical oncology : official journal of the American Society of Clinical OncologyMarcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus CD, Liu CG, Ruppert AS, Powell BL, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol. 2008 Nov 01; 26(31):5078-87.J Clin Oncol2008-09-22T00:00:002008Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.0.198620.03954225research area of0.8609390.036321713subject area for